The Surgalign Holdings, Inc. has reconfirmed its full year 2022 revenue outlook to be in the range of $86 to $90 million.
Surgalign Holdings, Inc.
Equities
SRGA
US86882C2044
Advanced Medical Equipment & Technology
1st Jan change | Capi. | |
---|---|---|
+9.22% | 3.4TCr | |
+23.32% | 815.99Cr | |
+31.37% | 426.09Cr | |
-30.15% | 264.56Cr | |
-19.11% | 139.79Cr | |
-28.03% | 127.44Cr | |
-33.21% | 116.55Cr | |
+13.85% | 101.82Cr | |
-34.50% | 92Cr |